Lymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
Lymphoid neoplasms Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
Hematol Oncol. 2020 Oct;38(4):432-438. doi: 10.1002/hon.2725. Epub 2020 Mar 3.
The meeting, which brought together leading scientists and clinicians in the field of leukemia and lymphoma, was held at the new headquarters of the Josep Carreras Leukaemia Research Institute (IJC) in Badalona, Catalonia, Spain, September 19-20, 2019. Its purpose was to highlight the latest advances in our understanding of the molecular mechanisms driving blood cancers, and to discuss how this knowledge can be translated into an improved management of the disease. Special emphasis was placed on the role of genetic and epigenetic heterogeneity, and the exploitation of epigenetic regulation for developing biomarkers and novel treatment approaches.
本次会议汇聚了白血病和淋巴瘤领域的顶尖科学家和临床医生，于 2019 年 9 月 19 日至 20 日在西班牙加泰罗尼亚巴达洛纳的 Josep Carreras 白血病研究所（IJC）新总部举行。会议旨在强调我们对推动血液癌症的分子机制的最新理解，并讨论如何将这些知识转化为改善疾病管理的方法。会议特别强调了遗传和表观遗传异质性的作用，以及利用表观遗传调控来开发生物标志物和新的治疗方法。
